Use of methamphetamine by young people: is there reason for concern?
Notice bibliographique
Résumé
The problem of methamphetamine (MA) use among adult populations world-wide persists and must be addressed [1], but there also is a need to examine MA use among young people [2]. Although epidemiological data from around the world present a mixed picture, in many regions of the world MA use by adolescents appears to be a significant public health problem. In the United States, federal government statistics minimize the problem of MA use by adolescents. For example, a national survey of 12th graders indicates a downward trend of life-time MA use from 1999 to 2005 (4.7% to 2.5%, respectively) [3]. However, state- and local-level data from treatment programs in some parts of the United States reveal that rates of treatment admissions of adolescents with diagnoses of MA abuse and dependence are more than 20% of all admissions and are increasing [4]. Although there is tremendous variability in youth MA rates across Europe, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) survey shows that the prevalence of methamphetamine/amphetamine use in youth aged 15–24 years has been rising since 1990 [5]. Findings from a Czech Republic survey [European School Survey Project on Alcohol and Other Drugs (ESPAD)] on 17–18-year-old students in 2003 indicate that nearly 8.4% had used MA (Pervitin) in their life-time and 5.4% had used in the previous year [6]. Data from Taiwan and northern Thailand also suggest that MA use is highly problematic among adolescents [7, 8]. According to the 2004 Australian National Drug Strategy Household Survey, the life-time MA use prevalence rate for youth aged 14–19 years is 6.6% [9]. Use in the previous 12 months was reported to be 4.4%, with female teenagers (4.9%) slightly more likely to be recent users than male teenagers (4.0%) [9]. Data from the Canadian Addiction Survey (2004) show that life-time MA use among older youth (15–19-year-olds and 20–24-year-olds) is high—8.3% and 11.2%, respectively [10]. In Cape Town, South Africa, treatment centres, 42% of admissions for 15–19-year-olds were for treatment of MA dependence in the second half of 2006 [11]. There is extensive evidence demonstrating MA's toxicity on the adult human brain when used at high doses over extended periods of time [12]. There is concern that MA abuse by young people, whose brains are still maturing and developing [13], could result in different types of neurological and psychiatric consequences. Although, to date, no published brain imaging studies have reported on young MA users, a growing body of animal studies is emerging [14], indicating that MA exposure causes different alterations in central nervous system serotonin and dopamine functions in adolescent animals than those produced in adults. Brain imaging studies with youth are needed to understand the long-term impact of MA use by young people. The limited clinical data which exist on MA-abusing adolescents suggest that these youth have a significant amount of psychiatric symptomatology. Several studies have reported that adolescents in treatment for MA abuse have higher levels of depressive symptoms and suicidal ideation than do adolescents in treatment for other substances (primarily marijuana and alcohol) [15]. Furthermore, MA abuse has been implicated in risky sexual behaviors (i.e. multiple sex partners and unprotected sexual intercourse) among youth in the United States [16]. MA use is especially problematic among girls, as evidenced by their much higher rates of admission into treatment programs compared to boys [3, 15]. Yen & Chong [17] report MA-using Taiwanese girls display higher rates of mood and eating disorders than do boys. Rawson & colleagues [15] found that MA-abusing girls reported higher levels of depression and suicidal tendencies than did MA-abusing boys. At present, only one study has reported data on preventive interventions aimed at reducing adolescents' MA use [18]. Results from this study suggest that effective prevention methods should focus on brief universal interventions, including reducing early initiation of substance use (i.e. alcohol, marijuana and tobacco), incorporating skills-building opportunities and alternative activities, and incorporating family and peer/social support [18]. The following strategies for preventing the use of MA by youths were suggested by experts on MA use and treatment providers from numerous countries at a United Nations Office on Drugs and Crime (UNODC) meeting in 2006 [1]: school-based activities (e.g. life skills training,training of teachers, use of positive reinforcement techniques), careful targeting of high-risk families for preschool interventions, using peer-based techniques to impart information and skills and empowering communities in order to reduce drug-related harm. There is limited understanding of effective treatment models for youth in the resolution of MA problems. While there are unique clinical issues associated with MA use, best practices for treating youth substance abuse, including integrative methods of treatment using cognitive behavioral techniques, motivational interviewing, family therapy and contingency management, should be incorporated into treatment models for MA-based intervention strategies. Gender and cultural differences also need to be considered when preventing and treating MA abuse. In some parts of the world, MA use by adolescents is a significant public health concern. Young women appear to be at special risk for developing MA-related problems and their use is associated with elevated levels of depression and suicidal thinking. High-risk sexual behaviors are associated with MA use, creating increased risk for sexually transmitted diseases, including HIV and hepatitis. There is a paucity of data on specific prevention and treatment approaches for reducing MA use among youth; however, general best practice principles are recommended.
Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.
Comment cette classification a été obtenuedéplier
Prédiction distillée sur la base complète
Imitation des enseignantsNi prévalence calibrée, ni vérité terrain. Validation humaine à venir. Apprise à partir de 10 348 étiquettes directes de Codex et de 10 348 étiquettes directes de Gemma. Le mode candidate est l'union des têtes enseignantes seuillées; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont ni des étiquettes humaines ni des étiquettes directes de modèles de pointe.
Scores Codex et Gemma par catégorie
| Catégorie | Codex | Gemma |
|---|---|---|
| Métarecherche | 0,000 | 0,001 |
| Méta-épidémiologie (sens strict) | 0,000 | 0,000 |
| Méta-épidémiologie (sens large) | 0,001 | 0,000 |
| Bibliométrie | 0,000 | 0,000 |
| Études des sciences et des technologies | 0,000 | 0,000 |
| Communication savante | 0,000 | 0,000 |
| Science ouverte | 0,000 | 0,000 |
| Intégrité de la recherche | 0,001 | 0,000 |
| Charge utile insuffisante (le modèle a refusé de juger) | 0,000 | 0,000 |
Scores machine (provisoires)
Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.
Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.
score_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découleClassification
machine, non validéePrédiction automatique; un appel candidat d’une seule tête enseignante, pas un consensus.
Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».